{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:32:28Z","timestamp":1781163148556,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI21\/00280"],"award-info":[{"award-number":["FI21\/00280"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIBERINFEC, ISCIII","award":["CB21\/13\/00006"],"award-info":[{"award-number":["CB21\/13\/00006"]}]},{"name":"CIBERINFEC, ISCIII","award":["CB21\/13\/00006"],"award-info":[{"award-number":["CB21\/13\/00006"]}]},{"name":"Servicio Andaluz de Salud, Junta de Andaluc\u00eda, Spain.","award":["RC1-0006-2023"],"award-info":[{"award-number":["RC1-0006-2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13554-7","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T03:01:59Z","timestamp":1754017319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of imipenem combined with dimercaptosuccinic acid in a murine sepsis model using Pseudomonas aeruginosa"],"prefix":"10.1038","volume":"15","author":[{"given":"Soraya","family":"Herrera-Espejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Findlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"Pach\u00f3n-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nordmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"13554_CR1","doi-asserted-by":"crossref","unstructured":"Horcajada, J.P. et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin. Microbiol. Rev. 32, (2019).","DOI":"10.1128\/CMR.00031-19"},{"key":"13554_CR2","doi-asserted-by":"crossref","unstructured":"Al-Orphaly, M. et al. Epidemiology of multidrug-resistant Pseudomonas aeruginosa in the Middle East and North Africa Region. mSphere 6, (2021).","DOI":"10.1128\/mSphere.00202-21"},{"key":"13554_CR3","doi-asserted-by":"crossref","unstructured":"Wang, M. G. et al. Retrospective data insight into the global distribution of carbapenemase-producing Pseudomonas aeruginosa. Antibiotics (Basel) 10, (2021).","DOI":"10.3390\/antibiotics10050548"},{"key":"13554_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","volume":"22","author":"WR Miller","year":"2024","unstructured":"Miller, W. R. & Arias, C. A. ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics. Nat. Rev. Microbiol. 22, 598\u2013616 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"13554_CR5","unstructured":"World Health Organization (WHO). Bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO., (2024)."},{"key":"13554_CR6","unstructured":"World Health Organization (WHO). Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO., (2017)."},{"key":"13554_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/CMR.00040-09","volume":"22","author":"PD Lister","year":"2009","unstructured":"Lister, P. D., Wolter, D. J. & Hanson, N. D. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22, 582\u2013610 (2009).","journal-title":"Clin. Microbiol. Rev."},{"key":"13554_CR8","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1128\/AAC.00513-10","volume":"54","author":"L Poirel","year":"2010","unstructured":"Poirel, L., Nordmann, P., Lagrutta, E., Cleary, T. & Munoz-Price, L. S. Emergence of KPC-producing Pseudomonas aeruginosa in the United States. Antimicrob. Agents Chemother. 54, 3072 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"13554_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1128\/CMR.00096-12","volume":"26","author":"HM Zowawi","year":"2013","unstructured":"Zowawi, H. M., Balkhy, H. H., Walsh, T. R. & Paterson, D. L. \u03b2-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin. Microbiol. Rev. 26, 361\u2013380 (2013).","journal-title":"Clin. Microbiol. Rev."},{"key":"13554_CR10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/22221751.2022.2048972","volume":"11","author":"FC Tenover","year":"2022","unstructured":"Tenover, F. C., Nicolau, D. P. & Gill, C. M. Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge. Emerg. Microbes Infect. 11, 811\u2013814 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"13554_CR11","doi-asserted-by":"publisher","first-page":"1060736","DOI":"10.3389\/fgene.2022.1060736","volume":"13","author":"V Arer","year":"2022","unstructured":"Arer, V. & Kar, D. Biochemical exploration of \u03b2-lactamase inhibitors. Front Genet. 13, 1060736 (2022).","journal-title":"Front Genet."},{"key":"13554_CR12","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/jac\/dkad210","volume":"78","author":"C Le Terrier","year":"2023","unstructured":"Le Terrier, C. et al. Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a one health concern. J. Antimicrob. Chemother. 78, 2382\u20132384 (2023).","journal-title":"J. Antimicrob. Chemother."},{"key":"13554_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/qjmed\/hcp114","volume":"102","author":"S Bradberry","year":"2009","unstructured":"Bradberry, S., Sheehan, T. & Vale, A. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning. QJM 102, 721\u2013732 (2009).","journal-title":"QJM"},{"key":"13554_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1389557043487583","volume":"4","author":"O Andersen","year":"2004","unstructured":"Andersen, O. Chemical and biological considerations in the treatment of metal intoxications by chelating agents. Mini. Rev. Med. Chem. 4, 11\u201321 (2004).","journal-title":"Mini. Rev. Med. Chem."},{"key":"13554_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001739","volume":"11","author":"N Thurtle","year":"2014","unstructured":"Thurtle, N. et al. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children \u2264 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data. PLoS Med. 11, e1001739 (2014).","journal-title":"PLoS Med."},{"key":"13554_CR16","doi-asserted-by":"crossref","unstructured":"Kosnett, M. J. Succimer (DMSA). In: Critical Care Toxicology (eds Brent J, Burkhart K, Dargan P, Hatten B, Megarbane B, Palmer R). Springer International Publishing (2016).","DOI":"10.1007\/978-3-319-20790-2_20-1"},{"key":"13554_CR17","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1093\/jac\/dkaa347","volume":"75","author":"G Cheminet","year":"2020","unstructured":"Cheminet, G. et al. Dimercaptosuccinic acid in combination with carbapenems against isogenic strains of Escherichia coli producing or not producing a metallo-\u03b2-lactamase in vitro and in murine peritonitis. J. Antimicrob. Chemother. 75, 3593\u20133600 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"13554_CR18","first-page":"120","volume":"54","author":"J Tannenbaum","year":"2015","unstructured":"Tannenbaum, J. & Bennett, B. T. Russell and Burch\u2019s 3Rs then and now: the need for clarity in definition and purpose. J. Am. Assoc. Lab. Anim. Sci. 54, 120\u2013132 (2015).","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"13554_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1089\/mdr.2024.0104","volume":"31","author":"M Bouvier","year":"2025","unstructured":"Bouvier, M., Freire, S., Findlay, J. & Nordmann, P. In-vitro activity of dimercaptosuccinic acid in combination with carbapenems against carbapenem-resistant pseudomonas aeruginosa. Microb. Drug Resist. 31, 16\u201320 (2025).","journal-title":"Microb. Drug Resist."},{"key":"13554_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1021\/acsinfecdis.2c00485","volume":"9","author":"BK Peters","year":"2023","unstructured":"Peters, B. K. et al. In vitro and in vivo development of a \u03b2-lactam-metallo-\u03b2-lactamase inhibitor: targeting carbapenem-resistant enterobacterales. ACS Infect. Dis. 9, 486\u2013496 (2023).","journal-title":"ACS Infect. Dis."},{"key":"13554_CR21","doi-asserted-by":"crossref","unstructured":"Principe, L. et al. Zinc chelators as carbapenem adjuvants for metallo-\u03b2-lactamase-producing bacteria: In Vitro and in vivo evaluation. Microb. Drug Resist. 26, 1133\u20131143 (2020).","DOI":"10.1089\/mdr.2020.0037"},{"key":"13554_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/jac\/dkq470","volume":"66","author":"M Souli","year":"2011","unstructured":"Souli, M. et al. Efficacy of carbapenems against a metallo-\u03b2-lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model. J. Antimicrob. Chemother. 66, 611\u2013617 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"13554_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/cc6994","volume":"12","author":"TG Slama","year":"2008","unstructured":"Slama, T. G. Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use. Crit. Care 12, 233 (2008).","journal-title":"Crit. Care"},{"key":"13554_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/15563650.2016.1221508","volume":"54","author":"JC van Eijkeren","year":"2016","unstructured":"van Eijkeren, J. C. et al. Modelling dimercaptosuccinic acid (DMSA) plasma kinetics in humans. Clin. Toxicol. (Phila) 54, 833\u2013839 (2016).","journal-title":"Clin. Toxicol. (Phila)"},{"key":"13554_CR25","first-page":"680","volume":"6","author":"B Floria\u0144czyk","year":"2000","unstructured":"Floria\u0144czyk, B. Zinc level in selected tissues of ethanol and morphine intoxicated mice. Med. Sci. Monit. 6, 680\u2013683 (2000).","journal-title":"Med. Sci. Monit."},{"key":"13554_CR26","doi-asserted-by":"crossref","unstructured":"Abdelraouf, K. et al. Deciphering the efficacy of \u03b2-lactams in the face of metallo-\u03b2-lactamase-derived resistance in enterobacterales: supraphysiologic zinc in the broth is the culprit. Open Forum Infect. Dis. 11, ofae228 (2024).","DOI":"10.1093\/ofid\/ofae228"},{"key":"13554_CR27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10096-024-04752-8","volume":"43","author":"J Findlay","year":"2024","unstructured":"Findlay, J., Raro, O. H. F., Poirel, L. & Nordmann, P. Molecular analysis of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Switzerland 2022\u20132023. Eur. J. Clin. Microbiol. Infect. Dis. 43, 551\u2013557 (2024).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"13554_CR28","unstructured":"EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0, 2025)."},{"key":"13554_CR29","doi-asserted-by":"crossref","unstructured":"Cai, Y. et al. Elimination of extracellular adenosine triphosphate for the rapid prediction of quantitative plate counts in 24 h time-kill studies against carbapenem-resistant gram-negative bacteria. Microorganisms 8, (2020).","DOI":"10.3390\/microorganisms8101489"},{"key":"13554_CR30","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1128\/AAC.00741-13","volume":"58","author":"T T\u00e4ngd\u00e9n","year":"2014","unstructured":"T\u00e4ngd\u00e9n, T. et al. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments. Antimicrob. Agents Chemother. 58, 1757\u20131762 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"13554_CR31","unstructured":"National Research Council (NRC). (US) Committee for the update of the guide for the care and use of laboratory animals. Guide for the care and use of laboratory animals. 8th edition. Washington (DC): National Academies Press (US); 2011.) (2011)."},{"key":"13554_CR32","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1128\/AAC.01367-09","volume":"54","author":"P Gobin","year":"2010","unstructured":"Gobin, P., Lema\u00eetre, F., Marchand, S., Couet, W. & Olivier, J. C. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry. Antimicrob. Agents Chemother. 54, 1941\u20131948 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"13554_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y., Huo, M., Zhou, J. & Xie, S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput. Methods Programs Biomed. 99, 306\u2013314 (2010).","journal-title":"Comput. Methods Programs Biomed."},{"key":"13554_CR34","doi-asserted-by":"crossref","unstructured":"Herrera-Espejo, S.  et al. Carbapenem combinations for infections caused by carbapenemase-producing Pseudomonas aeruginosa: experimental in vitro and in vivo analysis. Antibiotics (Basel) 11, (2022).","DOI":"10.3390\/antibiotics11091212"},{"key":"13554_CR35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13554-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13554-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13554-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:59:44Z","timestamp":1757325584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13554-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13554"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13554-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28047"}}